Abstract Treatment strategies to combat cardiogenic shock (CS) have remained stagnant
over the past decade. Mortality rates among patients who suffer CS after acute myocardial …

Background Cardiogenic shock remains a major cause of morbidity and mortality in patients
with ST-segment elevation myocardial infarction. We aimed to assess the current trends in …

Objectives This study presents the largest clinical experience of percutaneously placed
axillary intra-aortic balloon pump (IABP) in patients with advanced heart failure. Background …

Objectives: Review the anatomic and physiologic effects of the intra-aortic balloon pump.
Review the indications for the intra-aortic balloon pump procedure. Review the technique of …

The use of percutaneous mechanical circulatory support (MCS) devices, including Impella
and Intra-aortic balloon pump (IABP), in patients with cardiogenic shock has increased in …

Abstract According to the Global Burden of Disease Project, the morbidity and mortality of
myocarditis continue to be a significant worldwide burden. On October 1, 2015, hospital …

Purpose of review To provide a contemporary concise overview of the currently available
mechanical circulatory support (MCS) devices and the emerging concepts in the …

Background Prior studies have suggested intraaortic balloon pump (IABP) have a neutral
effect on acute myocardial infarction (AMI) patients with cardiogenic shock (CS). However …

Myocardial infarction complicated by cardiogenic shock (MI-CS) has a poor prognosis, even
with early revascularization. Previously, intra-aortic balloon pump (IABP) use was thought to …

The adverse outcomes of a ventricular heart failure (left, right or biventricular) caused by
cardiogenic shock are aggravated by lung oedema and organ mal perfusion. Despite …